阿布图斯生物制药

最新新闻

• Earnings Flash (ABUS) Arbutus Biopharma Corporation Reports Q3 Revenue $529,000, Vs. FactSet Est of $1.3M
  MT Newswires · 2025/11/13
• 评级变动
  H.C. Wainwright Sticks to Its Buy Rating for Arbutus Biopharma (ABUS)
  TipRanks · 2023/4/25
• 评级变动
  Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2024/11/20
• Earnings Flash (ABUS) Arbutus Biopharma Posts 2025 Total Revenue $14.1M, Vs. FactSet Est of $13.6M
  MT Newswires · 2026/3/23
• 评级变动
  H.C. Wainwright Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/1/21
• 评级变动
  Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $4
  \u5e02\u573a\u8d44\u8baf · 2024/8/2
• 评级变动
  JMP Securities Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/3/31
• ABUS Stock Has Given up Its Prior Gain. Arbutus Biopharma Shares Were Trading Higher After the Company Presented Clinical Trial Data From Its Two HBV Assets.
  Benzinga · 2025/5/7
• 评级变动
  H.C. Wainwright Sticks to Their Buy Rating for Arbutus Biopharma (ABUS)
  TipRanks · 2023/8/4
• 评级变动
  Robert W. Baird Remains a Hold on Arbutus Biopharma (ABUS)
  TipRanks · 2023/8/8
• 评级变动
  Jefferies Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $7
  \u5e02\u573a\u8d44\u8baf · 2024/9/6
• Earnings Flash (ABUS) Arbutus Biopharma Posts 2025 Loss $0.17 a Share, Vs. FactSet Est of $0.19 Loss
  MT Newswires · 2026/3/23
• 评级变动
  Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $4.5
  \u5e02\u573a\u8d44\u8baf · 2024/11/7
• 评级变动
  JMP Securities Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2024/8/2
• 评级变动
  H.C. Wainwright Keeps Their Buy Rating on Arbutus Biopharma (ABUS)
  TipRanks · 2023/9/12
• 评级变动
  H.C. Wainwright Remains a Buy on Arbutus Biopharma (ABUS)
  TipRanks · 2022/12/14
• Earnings Flash (ABUS) Arbutus Biopharma Posts Q1 EPS $0.87, Vs. FactSet Est of $0.03 Loss
  MT Newswires · 2026/5/13
• 评级变动
  Arbutus Biopharma (ABUS) Receives a Buy From H.C. Wainwright
  TipRanks · 2023/4/5

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。